1981
DOI: 10.1093/bja/53.4.373
|View full text |Cite
|
Sign up to set email alerts
|

4-Aminopyridine Reversal of Fentanyl-Induced Respiratory Depression in Normocapnic and Hypercapnic Patients

Abstract: Profound postoperative respiratory depression after larger doses of fentanyl was partially reversed by 4-aminopyridine. This reversal was independent of FIO2' suggesting that the response was not dependent upon peripheral chemoreceptor-mediated drive. Similar reversal of fentanyl-induced depression by 4-aminopyridine was observed before surgery in patients breathing 67% nitrous oxide in oxygen. 4-Aminopyridine had no effect on breathing when given alone in the absence of fentanyl to patients breathing 67% nitr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

1981
1981
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 0 publications
1
6
0
Order By: Relevance
“…From a study conducted on humans, Sia and Zandstra claim that 4-AP antagonizes respiratory depression after fentanyl. 16 The shortening of apnoea time in our patients is in accordance with those results.…”
Section: Discussionsupporting
confidence: 93%
“…From a study conducted on humans, Sia and Zandstra claim that 4-AP antagonizes respiratory depression after fentanyl. 16 The shortening of apnoea time in our patients is in accordance with those results.…”
Section: Discussionsupporting
confidence: 93%
“…More recently, studies in freely behaving rats have confirmed that blockade of potassium channels with several agents (barium, 4-AP, tetraethylammonium) constitutes an efficient strategy to increase genioglossus activity and reverse NREM hypotonia and REM atonia during sleep (5). Previous studies of 4-AP in humans revealed this drug was capable of reversing opioid-related respiratory depression in the postoperative setting (18,19). Furthermore, it is currently prescribed to improve motor functions in people suffering from multiple sclerosis (8), Figure 3.…”
Section: Discussionmentioning
confidence: 97%
“…While this work is largely still in the preclinical stage (for a thorough review of the preclinical literature see Imam et al 2020 ), a few clinical reports have examined respiratory stimulants (potassium channel blockers, N-methyl-D-aspartate receptor antagonists, ampakines, and analeptics), albeit with little-to-no evidence of utility during a real-life overdose event. 4-Aminopyridine, a potassium channel blocker, was the first reported to reverse respiratory depression caused by IV fentanyl (Sia and Zandstra 1981 ). However, 4-aminopyridine can have considerable side effects, including dysesthesias and dizziness (Blight and Henney 2009 ; Hayes et al 2003 ).…”
Section: Recent Advances In Overdose Treatments and Technologiesmentioning
confidence: 99%